Laboratory studies have demonstrated that bilirubin can affect a host of different cellular functions (1 1). Recent studies from our laboratory have shown that bilirubin toxicity in the neuroblastoma cell line N-115 was dependent on bilirubin concentration, B/A, and time of exposure (1 2). The effect on mitochondria1 function, [3H]thymidine uptake and ~~-[~'S]methionine uptake became manifest after 2 h of bilirubin exposure (12). As these vital cellular functions are affected by a short-term exposure to bilirubin, the N-115 cell line offers a good model system to study the early stages of bilirubin toxicity. The present study examines the reversibility of bilirubin toxicity in the early stages with respect to cellular function, as well as the possible delayed effects of a short-term exposure to three cellular functions, wherein no bilirubin toxicity was manifest. Contrary to the clinical situation, the present results indicate an irreversibility even in the early stages of bilirubin toxicity to the neural cell line.
ABSTRACT. Clinical studies have suggested that the early stages of bilirubin encephalopathy are reversible. These phenomena are investigated at the cellular level using the neuroblastoma cell line N-115 as a model system. To determine whether the cell line N-115 can recover from bilirubin toxicity, and whether the cellular function remains intact after a short period of bilirubin exposure during which time no toxic effects are manifest, the cells are exposed to bilirubin at varying concentrations and varying bi1irubin:albumin ratios for I and 2 h. The bilirubin is then washed out, and the cells are reincubated in fresh media with appropriate amounts of albumin. Mitochondria1 function, [3H]thymidine uptake and L-[35S]methionine uptake are assessed at 2, 8, and 24 h of reincubation after the bilirubin washout. After the short-term exposure, the cells begin to demonstrate evidence of toxicity in all parameters measured 8-24 h after the bilirubin washout. After the 2-h exposure to bilirubin, the cells demonstrate significant toxicity within 2 h of the bilirubin washout. The degree of toxicity seems to depend on the bi1irubin:albumin ratio and bilirubin concentration. In general, after bilirubin exposure of 1 h or longer, the N-115 cells develop evidence of toxicity in Hippocampal slices, and Wennberg (10) has shown a reversibility phenomenon in red blood cell and mitochondrial uptake of bilirubin.
Laboratory studies have demonstrated that bilirubin can affect a host of different cellular functions (1 1). Recent studies from our laboratory have shown that bilirubin toxicity in the neuroblastoma cell line N-115 was dependent on bilirubin concentration, B/A, and time of exposure (1 2). The effect on mitochondria1 function, [3H]thymidine uptake and ~~-[~'S]methionine uptake became manifest after 2 h of bilirubin exposure (12) . As these vital cellular functions are affected by a short-term exposure to bilirubin, the N-115 cell line offers a good model system to study the early stages of bilirubin toxicity. The present study examines the reversibility of bilirubin toxicity in the early stages with respect to cellular function, as well as the possible delayed effects of a short-term exposure to three cellular functions, wherein no bilirubin toxicity was manifest. Contrary to the clinical situation, the present results indicate an irreversibility even in the early stages of bilirubin toxicity to the neural cell line.
MATERIALS AND METHODS

which is progressive and irreversible. (Pediatr Res 25369-372,1989)
Cherniculs. All reagents are analytical grade chemicals and include bilirubin (Lot 13F0846), HSA (fraction v, essentially FFA-free) and MTT purchased from Sigma Chemical Co., St. Abbreviations Louis, MO. Bilirubin purity was verified as previously described B/A, bilirubin to albumin molar ratio (12 Clinical studies have recently suggested that in the presence of 7.4, at 37"C, in 5% COz humidified atmosphere for 12 h. The hyperbilirubinemia the newborn infant will demonstrate abnor-medium is then removed, the cells washed twice with sterile PBS ma1 evoked brain stem potentials, an indication of the early and reincubated in 1 mL of PFM (12) , plus HSA for another 12 stages of bilirubin encephalopathy. Upon resolution of the hy-h before setting up the experiments with bilirubin. The HSA and perbilirubinemia, either spontaneously or after exchange trans-bilirubin concentrations were varied in different experiments to fusion, these abnormalities disappear. This suggests a reversibility meet the required final B/A. to the early stages of bilirubin encephalopathy (1-3). The role of Experimental conditions. All procedures involving bilirubin albumin binding (4, 5) , the integrity of the blood brain barrier are carried out in a dimly lit room. Stock solutions of bilirubin ( 6 ) , and the possible presence of a bilirubin oxidase enzyme (7) in 0.1-N NaOH and HSA in PBS are prepared as described have been suggested as possible mechanisms in this phenome-previously (12) . Bilirubin is added to the culture medium to non. Cowger (8) below were carried out in triplicate analyses.
Toxicity is assessed at appropriate intervals as follows: I ) To assess cell viability and mitochondrial function, MTT is prepared and sterilized as described before (12) . Aliquots of 100 pL are added to the medium and incubated for 60 min. Then the cleaved dye is dissolved in 1 mL isopropanol-HCI (0.04 N), by agitation with repeated pipetting, until a blue solution is obtained. The absorbance of the individual culture dish is then read in a diode array spectrophotometer (Hewlett-Packard Co., Palo Alto, CA) with a test wavelength of 570 nm and a reference wavelength of 630 nm (13) . Only live cells will cleave the dye to give an increase in absorbance at 570 nm. The difference in absorbances at 570 and 630 nm is a direct measure of mitochondrial function and cell viability. To determine whether cells exposed to bilirubin, without evidence of toxicity, continue to function normally after a bilirubin washout and whether cells that already demonstrate bilirubin toxicity can recover their function once removed from bilirubin, 37 1 are given in Figure 1 and Table 1 . Cells exposed to bilirubin for 0.5 and 1 h show no effects on [3H]thymidine uptake and MTT assay. The cells appear to be functioning normally 8 h after the bilirubin washout. However, at 24 h there is a significant reduction in these cellular functions. In cells exposed to bilirubin for 2 h or longer, significant reduction in these functions are seen at 2 h after the bilirubin washout, and this effect is progressive with time. At 24 h, the cell viability is well below 20%. Similar results are obtained when toxicity is assessed by L-[35S]methionine uptake as seen in Figure 2 . The effect of varying bilirubin concentration on ['Hlthymidine uptake is demonstrated in Figure 3 . After exposure to bilirubin of 25, 50, 75, and 100 pM, B/A 1.5, the cells do not demonstrate any toxic effect for the first 8 h after the bilirubin washout. After 24 h, there is a significant decrease in [3H]thymidine uptake, which is more pronounced at 100 IrM bilirubin; 70% compared to 25% at 25-pM bilirubin. After a 2-h exposure to bilirubin, the suppression of [3H]thymidine uptake becomes apparent at 2 h after the bilirubin washout at concentrations above 50-,uM bilirubin. At 8 h and 24 h, ['Hlthymidine uptake is reduced at all concentrations of bilirubin, and this is more pronounced at the higher bilirubin concentrations (Fig. 3) .
The effect of varying B/A on bilirubin toxicity and the inability of the cells to regain normal function after this exposure is demonstrated in Figure 4 . After a 4-h exposure of the cells to medium containing constant HSA and variable bilirubin concentrations, the 2-h postbilirubin washout period is associated with mitochondria1 dysfunction after incubating the cells with solu- 
DISCUSSION
It is well established that bilirubin is toxic to neural cells; however, the mechanism and pathogenesis of its toxicity remains unclear (6, 8) . As preventive measures are taken very early during the course of neonatal hyperbilirubinemia, the number of cases with irreversible bilirubin encephalopathy are now of rare occurrence. However, clinical studies using auditory brainstem evoked responses in hyperbilirubinemic neonates have shown reversibility of the acute toxic effects of bilirubin. Once the hyperbilirubinemia has subsided, the abnormal responses were seen to normalize (1-3). A similar phenomenon has been suggested in laboratory studies on different cell systems (8-10, 16) .
The removal of tissue-bound bilirubin is thought to be a process comprising either changes in B/A, enzymatic oxidation of bilirubin, or clearance of bilirubin from otherwise undamaged brain tissue to the blood. By virtue of the albumin's affinity for bilirubin, the use of an albumin infusion during hyperbilirubinemia and/or exchange transfusion has been proposed as a means of protecting the infant's brain from the pigment and/or indeed removing the bilirubin from brain tissue (4, 17, 18) . Brodersen (7) has suggested the possibility of bilirubin oxidase enzymes within the neural cell, which might play a role in protecting the cell by oxidizing the unbound pigment. Bilirubin is capable of free diffusion across the lipid bilayer (19) and can effectively cross the cell membrane and move back into the circulation (6) .
What makes some bilirubin toxic effects reversible and others irreversible is unclear. Although the auditory brainstem evoked responses still needs further refinement before a definitive con-. clusion can be made (20) , in most of the laboratory studies, the. toxic effects have been observed under bilirubin concentrations and B/A not usually encountered in the clinical situation (1 7).
In the studies reported here, where stable bilirubin solution:; were used (21) , it was possible to demonstrate that bilirubin is indeed toxic to various cellular functions. Once toxicity appeared, this was irreversible, despite reincubation of the cell:; with fresh medium and HSA in the absence of bilirubin. More--over, after a short term exposure of 60 min, during which toxicity was not manifest, bilirubin-induced toxicity appeared later on. This can be used as an argument against the presence of a bilirubin oxidase enzyme system in the N-115 cell line. The presence of this enzyme in neural cells is speculative and to date has not been characterized. The fact that in this study the cell:; do not recover from bilirubin exposure and toxicity may be a reflection of the duration of the exposure and the higher B/A used. In the study recently reported by Wennberg (lo), the duration of bilirubin exposure was 15 min and B/A did not exceed 1.3. Under these conditions, he was able to remove bilirubin taken up by the red blood cell. The red blood cell is a known bilirubin-carrying agent and is a useful model for assessing bilirubin transport and bilirubin binding to tissues; as such, it may not necessarily reflect the mechanisms for bilirubin toxicity in neural intracellular organelles. Nonetheless in both cell systems and in the clinical situation, the amount of free bilirubin available and the duration of exposure would appear to be among the critical factors leading to the irreversible stage of bilirubin toxicity. The amount of free bilirubin present in a system is dependent on the albumin concentration. The binding and buffering capacity of plasma albumin to bilirubin begins to break down rapidly as the B/A approaches unity (22) . Moreover, albumin binding is transitory and reversible with the bound and the free bilirubin molecules undergoing rapid exchange (23) . These dynamic changes could account for the toxicity seen in cells exposed to solutions of B/A 21 and for the permanent effect of bilirubin on purified proteins (1 6). It is concluded that under appropriate conditions of bilirubin concentration. BIA, and time of exDosure. the bilirubin toxicity
